NEW YORK (GenomeWeb) – The year 2015 was a busy one for the genomics research tools and molecular diagnostics industries with an uptick in mergers and acquisitions, the unveiling of highly anticipated platforms and upgrades, and growing interest in NIPT and liquid biopsy technologies. Among the most-read articles on the GenomeWeb site for the year were those looking into the false-positive rates of NIPT, the naming of a panel to lead President Obama's Precision Medicine Initiative, and two articles on Oxford Nanopore. Below is a list of the 10 articles that gained the most interest among our readers in 2015.
1) NIPT Outperforms Standard Screening for T21 but False Positives Call for Caution, NEJM Studies Find
2) Roche's 454 Sues Thermo Fisher's Ion Torrent for Patent Infringement
3) Oxford Nanopore Releases Pricing for MinIon Flow Cells as Users Publish New Data, Applications
4) Roche Acquires CAPP Medical for ctDNA Cancer Screening, Monitoring Technology
5) FDA Approves First PARP Inhibitor with Myriad's BRACAnalysis as CDx in Advanced Ovarian Cancer
6) Promise of Liquid Biopsy as Clinical Tool Continues to Grow Among Cancer Researchers
7) BGI's Complete Genomics Launches New NGS System Capable of Sequencing 10K Genomes Per Year
8) NIH Names Panel to Lead Obama's Precision Medicine Initiative
9) Oxford Nanopore Outlines Specs for New Sequencers, Automated Sample Prep System, Pay-As-Go Pricing
10) Study Highlights High False Positive Rate of NIPT for Some Disorders Despite High Specificity